Valid accounts are being leveraged as an initial attack vector in 2024, representing 31.4% of cases. This, according to an ...

In a series of three recent studies, a team led by CSIC researcher at CRAG Ana I. Caño-Delgado has made significant progress ...

Leading global telco inks multi-year partnership with satellite operators for low Earth orbit (LEO) connectivity and terrestrial comms infrastructure.

“When scaling up a process based on adherent cells, a biopharmaceutical manufacturer has two options. Either stay in 2D, resulting in the use of heavy and difficult-to-handle multi-tray stacks with a ...

In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with ...

BrandAlley, a UK-based designer and luxury fashion online retailer, has over eight million members, adds thousands of new ...

Strasbourg (France), March 11, 2025, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today ...

Vector Informatik has collaborated with Synopsys to fast-track the development of software-defined vehicle (SDV) in the ...

Development strategies designed to reduce the unknowns so that cell and gene therapy innovators can develop robust processes ...

Synopsys partners with Vector to advance software-defined vehicles, cutting costs and improving software quality.

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

Learn how Claude 3.7 Sonnet empowers businesses with AI-driven automation, simplifying tasks and boosting productivity ...